Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Australian Pharmaceutical Industries Limited
  6. Summary
    API   AU000000API4

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED

(API)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
1.52(c) 1.52(c) 1.51(c) 1.515(c) 1.5(c) Last
1 016 598 1 731 524 4 340 570 1 364 288 4 452 770 Volume
+0.33% 0.00% -0.66% +0.33% -0.99% Change
More quotes
Estimated financial data (e)
Sales 2022 4 137 M 2 962 M 2 962 M
Net income 2022 45,5 M 32,6 M 32,6 M
Net Debt 2022 98,9 M 70,8 M 70,8 M
P/E ratio 2022 16,0x
Yield 2022 3,96%
Sales 2023 4 214 M 3 017 M 3 017 M
Net income 2023 54,1 M 38,7 M 38,7 M
Net Debt 2023 62,3 M 44,6 M 44,6 M
P/E ratio 2023 13,3x
Yield 2023 4,75%
Capitalization 739 M 528 M 529 M
EV / Sales 2022 0,20x
EV / Sales 2023 0,19x
Nbr of Employees -
Free-Float -
More Financials
Company
Australian Pharmaceutical Industries Limited is an Australia-based pharmaceutical distributor, and health and beauty retailer company. The CompanyÔÇÖs segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and... 
Sector
Drug Retailers
Calendar
04/21Earnings Release
More about the company
Ratings of Australian Pharmaceutical Industries Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
01/19AUSTRALIAN PHARMACEUTICAL INDUSTRIES : 2021 AGM - Presentation to Shareholders
PU
01/16Australia's Wesfarmers flags lower first-half profit hurt by coronavirus curbs
RE
01/14AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Change in substantial holding from MUFG
PU
01/07Australian Shares Recoup Some Losses on Bargain Hunting
MT
01/07Financials, energy stocks lead rebound in Australian shares
RE
01/06Woolworths Withdraws $609 Million Takeover Proposal for Australian Pharmaceutical Indus..
MT
01/06Australian shares rebound as financials gain, James Hardie sinks
RE
01/06Wesfarmers to buy Australia's API for $547 mln after Woolworths backs out
RE
01/06API Acquisition by Wesfarmers on Track After Woolworths Withdraws
DJ
2021AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Change in substantial holding from MUFG
PU
2021Rob Scott Opposes Bid from Woolies to Australian Pharmaceutical
CI
2021Australian Pharmaceutical Industries Declares Final Dividend
MT
2021Gold, tech stocks drag Australian shares lower
RE
2021Wesfarmers Opposed to Woolworths' Rival Approach for API -- Update
DJ
2021AUSTRALIAN PHARMACEUTICAL INDUSTRIES : FY21 Sustainability Report
PU
More news
News in other languages on AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
01/16L'australien Wesfarmers annonce une baisse de son bénéfice au premier semestre en raiso..
01/07Les actions australiennes regagnent un peu de terrain grâce à la chasse aux bonnes affa..
01/06Woolworths retire sa proposition de rachat de 609 millions de dollars d'Australian Phar..
01/06Wesfarmers va racheter l'entreprise australienne API pour 547 millions de dollars après..
2021Australian Pharmaceutical Industries déclare un dividende final
More news
Chart AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Australian Pharmaceutical Industries Limited Technical Analysis Chart | API | AU000000API4 | MarketScreener
Technical analysis trends AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 1,50 AUD
Average target price 1,59 AUD
Spread / Average Target 6,00%
EPS Revisions
Managers and Directors
Richard Craig Vincent Chief Executive Officer, MD & Executive Director
Peter Mendo Chief Financial Officer
Kenneth William Gunderson-Briggs Independent Non-Executive Officer
Dean D. Matthews Chief Information Officer
Lee Ausburn Independent Non-Executive Director